vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and AvalonBay Communities (AVB). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $767.9M, roughly 1.3× AvalonBay Communities). AvalonBay Communities runs the higher net margin — 9040.6% vs 7.7%, a 9032.9% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 3.7%). AvalonBay Communities produced more free cash flow last quarter ($1.4B vs $96.9M). Over the past eight quarters, AvalonBay Communities's revenue compounded faster (3.8% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.
ATR vs AVB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $767.9M |
| Net Profit | $74.3M | $166.0M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | 64.2% |
| Net Margin | 7.7% | 9040.6% |
| Revenue YoY | 13.5% | 3.7% |
| Net Profit YoY | -26.4% | -41.2% |
| EPS (diluted) | $1.13 | $1.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $767.9M | ||
| Q3 25 | $961.1M | $766.8M | ||
| Q2 25 | $966.0M | $760.2M | ||
| Q1 25 | $887.3M | $745.9M | ||
| Q4 24 | $848.1M | $740.5M | ||
| Q3 24 | $909.3M | $734.3M | ||
| Q2 24 | $910.1M | $726.0M | ||
| Q1 24 | $915.4M | $712.9M |
| Q4 25 | $74.3M | $166.0M | ||
| Q3 25 | $127.9M | $381.3M | ||
| Q2 25 | $111.7M | $268.7M | ||
| Q1 25 | $78.8M | $236.6M | ||
| Q4 24 | $100.9M | $282.1M | ||
| Q3 24 | $100.0M | $372.5M | ||
| Q2 24 | $90.5M | $253.9M | ||
| Q1 24 | $83.1M | $173.4M |
| Q4 25 | 11.0% | 64.2% | ||
| Q3 25 | 14.2% | 65.7% | ||
| Q2 25 | 14.9% | 67.6% | ||
| Q1 25 | 12.8% | 68.5% | ||
| Q4 24 | 14.2% | 63.1% | ||
| Q3 24 | 15.2% | 65.4% | ||
| Q2 24 | 13.8% | 66.6% | ||
| Q1 24 | 12.2% | 67.2% |
| Q4 25 | 7.7% | 9040.6% | ||
| Q3 25 | 13.3% | 49.7% | ||
| Q2 25 | 11.6% | 35.3% | ||
| Q1 25 | 8.9% | 31.7% | ||
| Q4 24 | 11.9% | 38.1% | ||
| Q3 24 | 11.0% | 50.7% | ||
| Q2 24 | 9.9% | 35.0% | ||
| Q1 24 | 9.1% | 24.3% |
| Q4 25 | $1.13 | $1.18 | ||
| Q3 25 | $1.92 | $2.68 | ||
| Q2 25 | $1.67 | $1.88 | ||
| Q1 25 | $1.17 | $1.66 | ||
| Q4 24 | $1.48 | $1.99 | ||
| Q3 24 | $1.48 | $2.61 | ||
| Q2 24 | $1.34 | $1.78 | ||
| Q1 24 | $1.23 | $1.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $187.2M |
| Total DebtLower is stronger | $1.1B | $9.3B |
| Stockholders' EquityBook value | $2.7B | $11.6B |
| Total Assets | $5.3B | $22.2B |
| Debt / EquityLower = less leverage | 0.43× | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $187.2M | ||
| Q3 25 | $264.8M | $123.3M | ||
| Q2 25 | $169.8M | $102.8M | ||
| Q1 25 | $136.8M | $53.3M | ||
| Q4 24 | $226.2M | $108.6M | ||
| Q3 24 | $327.9M | $552.4M | ||
| Q2 24 | $223.9M | $545.8M | ||
| Q1 24 | $201.1M | $287.9M |
| Q4 25 | $1.1B | $9.3B | ||
| Q3 25 | $546.0M | $8.7B | ||
| Q2 25 | $535.1M | $8.7B | ||
| Q1 25 | $561.2M | $8.3B | ||
| Q4 24 | $688.1M | $8.1B | ||
| Q3 24 | $822.7M | $8.4B | ||
| Q2 24 | $681.5M | $8.4B | ||
| Q1 24 | $680.4M | $8.0B |
| Q4 25 | $2.7B | $11.6B | ||
| Q3 25 | $2.8B | $11.9B | ||
| Q2 25 | $2.7B | $11.9B | ||
| Q1 25 | $2.5B | $11.9B | ||
| Q4 24 | $2.5B | $11.9B | ||
| Q3 24 | $2.5B | $11.9B | ||
| Q2 24 | $2.4B | $11.7B | ||
| Q1 24 | $2.3B | $11.7B |
| Q4 25 | $5.3B | $22.2B | ||
| Q3 25 | $5.1B | $21.9B | ||
| Q2 25 | $4.9B | $21.8B | ||
| Q1 25 | $4.5B | $21.2B | ||
| Q4 24 | $4.4B | $21.0B | ||
| Q3 24 | $4.6B | $21.3B | ||
| Q2 24 | $4.5B | $21.0B | ||
| Q1 24 | $4.4B | $20.6B |
| Q4 25 | 0.43× | 0.80× | ||
| Q3 25 | 0.20× | 0.73× | ||
| Q2 25 | 0.20× | 0.72× | ||
| Q1 25 | 0.22× | 0.70× | ||
| Q4 24 | 0.28× | 0.68× | ||
| Q3 24 | 0.32× | 0.70× | ||
| Q2 24 | 0.28× | 0.71× | ||
| Q1 24 | 0.29× | 0.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $1.7B |
| Free Cash FlowOCF − Capex | $96.9M | $1.4B |
| FCF MarginFCF / Revenue | 10.1% | 183.5% |
| Capex IntensityCapex / Revenue | 9.0% | 34.1% |
| Cash ConversionOCF / Net Profit | 2.47× | 10.07× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $2.5B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $1.7B | ||
| Q3 25 | $177.6M | $477.0M | ||
| Q2 25 | $126.0M | $377.8M | ||
| Q1 25 | $82.7M | $415.9M | ||
| Q4 24 | $178.2M | $1.6B | ||
| Q3 24 | $229.3M | $486.2M | ||
| Q2 24 | $143.6M | $380.0M | ||
| Q1 24 | $92.3M | $412.9M |
| Q4 25 | $96.9M | $1.4B | ||
| Q3 25 | $114.3M | $402.2M | ||
| Q2 25 | $62.5M | $317.1M | ||
| Q1 25 | $25.9M | $367.5M | ||
| Q4 24 | $112.2M | $1.4B | ||
| Q3 24 | $162.7M | $434.2M | ||
| Q2 24 | $75.4M | $333.0M | ||
| Q1 24 | $16.7M | $375.4M |
| Q4 25 | 10.1% | 183.5% | ||
| Q3 25 | 11.9% | 52.5% | ||
| Q2 25 | 6.5% | 41.7% | ||
| Q1 25 | 2.9% | 49.3% | ||
| Q4 24 | 13.2% | 191.0% | ||
| Q3 24 | 17.9% | 59.1% | ||
| Q2 24 | 8.3% | 45.9% | ||
| Q1 24 | 1.8% | 52.7% |
| Q4 25 | 9.0% | 34.1% | ||
| Q3 25 | 6.6% | 9.8% | ||
| Q2 25 | 6.6% | 8.0% | ||
| Q1 25 | 6.4% | 6.5% | ||
| Q4 24 | 7.8% | 26.1% | ||
| Q3 24 | 7.3% | 7.1% | ||
| Q2 24 | 7.5% | 6.5% | ||
| Q1 24 | 8.3% | 5.3% |
| Q4 25 | 2.47× | 10.07× | ||
| Q3 25 | 1.39× | 1.25× | ||
| Q2 25 | 1.13× | 1.41× | ||
| Q1 25 | 1.05× | 1.76× | ||
| Q4 24 | 1.77× | 5.70× | ||
| Q3 24 | 2.29× | 1.31× | ||
| Q2 24 | 1.59× | 1.50× | ||
| Q1 24 | 1.11× | 2.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
AVB
Segment breakdown not available.
